AM, D., CC, G., E, E., C, A., D, D., MI, N., . . . TM, B. (2026). Aflibercept and Brolucizumab in Diabetic Macular Edema: A Focused Review of Efficacy, Safety, and Clinical Considerations. Biomedicines, 14(3), . https://doi.org/10.3390/biomedicines14030501
Chicago Style (17th ed.) CitationAM, Dascalu, et al. "Aflibercept and Brolucizumab in Diabetic Macular Edema: A Focused Review of Efficacy, Safety, and Clinical Considerations." Biomedicines 14, no. 3 (2026). https://doi.org/10.3390/biomedicines14030501.
MLA (9th ed.) CitationAM, Dascalu, et al. "Aflibercept and Brolucizumab in Diabetic Macular Edema: A Focused Review of Efficacy, Safety, and Clinical Considerations." Biomedicines, vol. 14, no. 3, 2026, https://doi.org/10.3390/biomedicines14030501.
Warning: These citations may not always be 100% accurate.
